BFM
CEMI

Boothbay Fund Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Boothbay Fund Management’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22,832
Closed -$80K – 2322
2021
Q1 		$80K Hold
22,832
– – ﹤0.01% 1482
2020
Q4 		$108K Buy
+22,832
New +$118K ﹤0.01% 1179
2020
Q3 		– Sell
-46,745
Closed -$152K – 1386
2020
Q2 		$152K Sell
46,745
-26,889
-37% -$255K 0.01% 833
2020
Q1 		$377K Sell
73,634
-48,827
-40% -$198K 0.03% 510
2019
Q4 		$558K Buy
122,461
+9,211
+8% +$44.9K 0.05% 461
2019
Q3 		$693K Buy
113,250
+21,342
+23% +$127K 0.06% 391
2019
Q2 		$560K Buy
91,908
+25,109
+38% +$169K 0.05% 385
2019
Q1 		$371K Buy
66,799
+34,949
+110% +$227K 0.04% 454
2018
Q4 		$180K Buy
+31,850
New +$235K 0.03% 505

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Boothbay Fund Management's CEMI Position: Q2 2021 in Review

Boothbay Fund Management sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2021, closing a stake of 22,832 shares — an estimated $80K sold.

Boothbay Fund Management first reported a position in CEMI in Q4 2018 and held it in 9 quarters. The position peaked at $693K in Q3 2019. 60 funds tracked by Wall St. Rank hold CEMI as of Q2 2021.

  • Boothbay Fund Management reported no remaining Chembio diagnostics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 22,832 Chembio diagnostics, Inc. shares in Q2 2021, an estimated $80K.
  • Boothbay Fund Management first reported a position in Chembio diagnostics, Inc. in Q4 2018 and held it in 9 quarters.
  • Boothbay Fund Management's Chembio diagnostics, Inc. position peaked at $693K in Q3 2019.
  • 60 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2021.

Based on Boothbay Fund Management's 13F filing for Q2 2021, filed 16 Aug 2021.